KSBNS 2023

The 26th Annual Meeting of the Korean Society for Brain and Neural Sciences

September 6(Wed)-8(Fri), 2023
BEXCO, Busan, South Korea

Sponsor Seminars

KSBNS Sponsor Seminars are organized by our corporate sponsors to provide an opportunity to experience in-depth presentations of their new products and cutting-edge technologies. These seminars offer both industries and attendees hands-on time with scientific innovations.

Sponsor Seminar 1 Bio-Medical Science Co., Ltd.

  • Sponsor Seminar 1 Bio-Medical Science Co., Ltd.

    • Date September 6
    • Time 12:00-12:30
    • Location Hall 1

    Title · A modular approach to modeling disease in 3D neural spheroids using human iPSC-derived cell types
    Speaker · Katherine Czysz (FUJIFILM Cellular Dynamics Products)

    3D neural spheroids are a rapidly developing technology with great potential for understanding neurodegenerative disease and neurodevelopmental disorders. Generation of spheroids using directed differentiation of neural progenitor cells or induced pluripotent stem cells (iPSCs) is time-consuming, variable, and restrictive for analyzing disease phenotypes within specific cells. This presentation demonstrates an efficient and modular approach for creating disease-specific neural spheroids by combining fully differentiated iPSC-derived neural cells in tri-culture. Data will focus on modeling Parkinson's Disease, Alzheimer's Disease, and epilepsy using iPSCs-derived neurons containing patient or engineered disease-related mutations.

Sponsor Seminar 5 CHAYON Laboratories, Inc.

  • Sponsor Seminar 5 CHAYON Laboratories, Inc.

    • Date September 7
    • Time 12:00-12:30
    • Location Hall 1

    Title · Neuro-Nanoimaging based on super resolution imaging platform
    Speaker · Suna Kang (Chayon Laboratories Inc.)

    The Nanoimager platform enables single-molecule neuroimaging of cultured neuronal cells and brain tissue sections, with a resolution reaching 20 nm. Combining automation features with super-resolution imaging allows the quick and efficient identification of region of interests to then gather localizations from thousands of synaptic proteins. It also facilitates acquisition of data on single molecule distribution, co-localization, or postsynaptic density profiles.

Sponsor Seminar 6 Rhino Bio, Inc.

  • Sponsor Seminar 6 Rhino Bio, Inc.

    • Date September 7
    • Time 12:00-12:30
    • Location Hall 2

    Title · Functional neurological disease modeling: organoids, gene therapy, and beyond
    Speaker · Mike Clements (Axion BioSystems)

    Neurological disorders represent a leading cause of death and disability, yet treatments remain limited due to complexity of the brain and successful therapeutic evaluation. Advances in induced pluripotent stem cell (hiPSC) protocols and accessibility are producing more physiologically relevant models, including brain organoids, that better recapitulate disease phenotypes. Similarly, genetic engineering technologies (e.g., CRISPR/Cas9) allow for rare disease modeling and targeting specific mutations as a therapeutic approach. Functional analysis, such as multielectrode array (MEA) electrophysiology, is key to enabling researchers to assess disease phenotypes and evaluate potential therapeutics.